Lipocine Inc.
LPCN
$2.11
$0.052.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -162.94% | -112.93% | -114,713.10% | -34.99% | 46.90% |
| Total Depreciation and Amortization | 4.84% | 24.48% | 47.93% | 83.28% | 70.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 82.34% | 102.61% | 116.15% | 107.87% | -106.69% |
| Change in Net Operating Assets | 277.32% | 2,380.14% | 74.75% | 156.26% | -133.05% |
| Cash from Operations | -124.42% | -79.50% | -699.21% | -3.92% | -5.68% |
| Capital Expenditure | -- | -- | -- | 88.80% | -879.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -211.93% | -154.51% | 132.28% | 13.10% | 18.32% |
| Cash from Investing | -213.79% | -155.38% | 140.82% | 15.15% | 16.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21,424.60% | 6,990.54% | 1,271.00% | 3.63% | -87.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21,424.60% | 6,726.36% | 1,271.00% | 6.32% | -87.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -316.93% | 507.79% | -169.73% | 147.98% | -8.91% |